News and Trends 7 Feb 2023
AAHI bags $9.9M to develop nasal spray influenza RNA vaccine
The Access to Advanced Health Institute (AAHI) has been awarded a project agreement worth up to $9.9 million through the…
influenza
- Latest Posts
News and Trends 17 Jan 2023
Poolbeg expands POLB 001 into oncology
Poolbeg Pharma has announced the strategic expansion of POLB 001 into oncology. POLB 001 is a strain agnostic, small molecule…
News and Trends 13 Dec 2022
Poolbeg influenza trial successfully completed
Poolbeg Pharma has received initial results having completed its lipopolysaccharide (LPS) human challenge clinical trial for POLB 001, a viral…
Startup Scout 21 Nov 2022
Osivax is designing future-proof influenza and Covid vaccines
Viruses causing influenza and COVID-19 continually evolve to escape our vaccine protections. The French firm Osivax is developing vaccines that…
ADVERTISEMENT
News and Trends 3 Nov 2022
Virax Biolabs introduces flu, Covid-19 and RSV rapid test kits
Rapid test kits that can accurately identify infections related to respiratory syncytial virus (RSV), influenza and Covid-19 can deliver results…
News and Trends 4 Oct 2022
Patents granted for Poolbeg Pharma influenza and respiratory virus infections treatments
Poolbeg Pharma has been granted patents by the US Patent and Trademark Office (USPTO) for POLB 001, a small molecule…
News and Trends 16 Aug 2022
Pneumagen embarks on phase 2 proof of concept influenza study
Biotech company Pneumagen says the first person has been dosed in its phase 2 controlled human infection challenge study. Its…
News and Trends 15 Aug 2022
Roche announces influenza drug approval and new COVID test
Roche has announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for…
News and Trends 22 Jul 2022
Beyond Biotech podcast 6: Mogrify, +ND Capital, Poolbeg Pharma
On this week’s podcast, our guests are Jeremy Skillington, CEO of Poolbeg Pharma; Dani Bach, and Eric Moessinger, both partners…
News and Trends 21 Jul 2022
Poolbeg Pharma gets approval for severe influenza drug trial
Poolbeg Pharma, a clinical stage infectious disease pharmaceutical company, has received ethics and competent authority approval to commence its lipopolysaccharide…
ADVERTISEMENT
News and Trends 21 Jul 2022
Additional funding for trial to study drug targeting lung immunity in elderly patients
Lung immunity in the elderly will be the subject of a controlled clinical trial after receiving clearance to go ahead…
News and Trends 19 Jul 2022
SINOVAC starts influenza vaccine trial in Chile
Sinovac Biotech Ltd., a provider of biopharmaceutical products in China, has initiated a phase III clinical trial for SINOVAC’s inactivated…
News and Trends 23 Jun 2022
Osivax gets €10M influenza vaccine grant
A grant of €10 million ($10.5 million) has been secured by pharmaceutical company Osivax to support a vaccine against influenza. …